Internal Medicine, Rheumatology · Grand Blanc, MI
NPI
1871520239
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
6
Medicare group memberships
Hospitals
3
Hospital affiliations
8200 S Saginaw St Ste 500
Grand Blanc, MI, 48439
Phone (810) 953-8700
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
12,581 services
Medicare patients, 2024
279
Average age 71
Drug cost, 2024
$4.1M
3,715 prescriptions
Company payments, 2025
$4,682
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali A Karrar was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,962 times for 28 patients. In total Ali A Karrar billed 12,581 services in 42 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,962 | 28 | $0.10 | $202 |
| 99214 Office E&M - Established | Office | 541 | 228 | $83.07 | $45K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 107 | 79 | $12.55 | $1,343 |
| 96372 Injection Administration | Office | 60 | 33 | $10.13 | $608 |
| 77080 Standard X-ray | Office | 48 | 48 | $35.43 | $1,700 |
| 76881 Ultrasound - Nonspecific | Office | 44 | 24 | $36.19 | $1,593 |
| 20610 Joint Injection | Office | 43 | 22 | $48.10 | $2,068 |
| 99232 Hospital E&M - Subsequent | Facility | 41 | 17 | $62.12 | $2,547 |
| 99204 Office E&M - New | Office | 40 | 40 | $108.50 | $4,340 |
| 99215 Office E&M - Established | Office | 27 | 17 | $128.84 | $3,479 |
| 99205 Office E&M - New | Office | 14 | 14 | $167.78 | $2,349 |
By year: 2022 $190K for 8,315 services; 2023 $219K for 9,731 services; 2024 $202K for 12,581 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ali A Karrar prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 847 prescriptions and refills. In total Ali A Karrar wrote 3,715 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 847 | 2,054 | 336 | $59K |
| Methotrexate Methotrexate Sodium | 719 | 1,619 | 258 | $34K |
| Methylprednisolone Generic | 423 | 433 | 280 | $2,477 |
| Prednisone Generic | 234 | 466 | 113 | $1,581 |
| Humira(Cf) Pen Adalimumab | 154 | 156 | 23 | $1.0M |
| Meloxicam Generic | 152 | 175 | 54 | $531 |
| Alendronate Sodium Generic | 136 | 304 | 48 | $1,389 |
| Enbrel Sureclick Etanercept | 135 | 144 | 24 | $1.0M |
| Diclofenac Sodium Generic | 106 | 120 | 52 | $3,844 |
| Leflunomide Generic | 99 | 230 | 38 | $7,047 |
| Folic Acid Generic | 68 | 162 | 25 | $288 |
| Leucovorin Calcium Generic | 53 | 102 | 16 | $1,217 |
| Enbrel Etanercept | 46 | 48 | Under 11 | $318K |
| Tramadol Hcl Generic | 37 | 46 | Under 11 | $86.99 |
| Humira Pen Adalimumab | 32 | 35 | Under 11 | $231K |
Brand drugs: 672 claims; generic drugs: 3,032 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali A Karrar $4,682 ($4,682 in general payments such as food, travel and fees) from 27 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $1,101.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $1,101 |
| Amgen Inc. AMGN | 51 | $719 |
| Janssen Biotech, Inc. JNJ | 24 | $673 |
| Abbvie Inc. ABBV | 29 | $671 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $361 |
| Genzyme Corporation SNY | 8 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $143 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $115 |
| Organon LLC OGN | 4 | $99.01 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $78.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.